Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • DPIFF, India’s Most Prestigious Film Festival & Award Ceremony, Announces H.H. Radhikaraje Gaekwad as Advisory Board Member Press Release
  • Bridging Ancient Wisdom and Modern Leadership: The Journey of Sridhar Rammurthy Lifestyle
  • Gain & Grow – A New Era of Stock Market Trading Business
  • Entrepreneur Sahil Narang Expands His Empire with the Launch of Amigo Holiday Homes and Amigo Car Rental Business
  • Emerald Tyre – An Indian Tyre Manufacturer Plans To Acquire 65% Stake In A South African Tyre Company To Expand Its Volumes In US Market Business
  • 14th Asia Africa Business & Social Forum: Awards & Business E-Summit Business
  • Why Dr. Ranjit Jagtap and Ram Mangal Heart Foundation is a trusted name in Heart Care in Pune? Business
  • Jar, India’s first micro-savings app, raises $22.6 million in Tiger Global-led Series B funding at over $300 million valuation Business

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Meitra Hospital Announces Launch of Robotic Joint Replacement Surgery Health
  • CritiCare Asia Hospitals launches Smith+Nephew CORI robotic system for joint replacements Health
  • Medical Breakthrough: Preserve Your Natural Knee with Absolute Precision Robotic Microplasty Surgical Technique Health
  • Beyond the Belly: How Cranberries Strengthen the Gut from Within Health
  • IPA MP State Branch, Indore Received Special Appreciation Award at Ipc-2023 Held in Nagpur: Dr. Anil Kharia, Honorary President, IPA MP STATE BRANCH Received the National Award during IPC 2023 Health
  • Advanced Homeopathy treatment brings New Hope to Aplastic Anemia Patients: Dr. A.K. Dwivedi’s Efforts Shine Health

Recent Posts

  • Jainam’s ‘Kal Jaante Hain, Kal Banaate Hain’ Cuts Through the Noise of an Always-On Market
  • FLYTTA GREEN Introduces Heavy-Duty Electric Trucks for Dalmia Cement in Partnership with Drivn
  • ACTIZEET® Cares Launches Emergency Flood Relief Initiative for Families Affected by the Assam Floods
  • NIS Management Limited Secures ₹7.93 Cr DDU-GKY Skill Development Project in Odisha
  • NoBroker Launches India’s First Eco-Smart Home Cleaning Service with Odourless, Non-Corrosive and Family-Safe Solutions

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Reena Rai is back with the 5th season of Miss TransQueenIndia, supported by Deepa Ardhnareshwar Empowerment Foundation Business
  • IMS Ghaziabad (University Courses Campus) Students Embark on an Educational and Cultural Journey to Malaysia Education
  • Petro Industries: Leading the Way in Hardware and Bathroom Accessories Manufacturing Business
  • First Announcement: Janmmejaya Headlines ‘Ramyaa’, A Powerful Title-Role Film Directed By Santosh Parab Entertainment
  • Entrepreneur, e-commerce giant and Qualified Investor Freedman Band Business
  • Hire in Global Reports Record Revenue Growth for 2024 Business
  • Doctor’s Day Special: Expert Insights on Modern Innovations in Fertility Treatment Health
  • Jim Corbett witnessed Cell Based Medicine in the Making Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme